Cypre, Inc.

Cypre is a biotechnology company dedicated to overcoming therapeutic resistance for cancer patients. Our 3D Tumor Model Platform engineers the tumor microenvironment in vitro at high throughput for drug efficacy and MOA studies. We are now applying the platform with therapeutic innovators for drug discovery and combination screening across various modalities - small molecules, biologics, and cell therapy. 3D tumor models for improving cancer therapy and immunotherapy for patients, from drug discovery to the clinic.